Novo Nordisk Makes Bold Move in Obesity Market with New Triple Agonist Danish biopharma giant Novo Nordisk is making waves…
Browsing: Lilly
The FDA’s recent decisions regarding compound GLP-1s have had a significant impact on the obesity drug market, particularly for pharma…
Manufacturing investments have become a focal point in the pharmaceutical industry in recent years, with companies like Eli Lilly and…
AI and RNA genetic-medicine company Genetic Leap has announced a groundbreaking partnership with pharmaceutical giant Eli Lilly to develop innovative…
Pharmaceutical Giant Lilly Launches SGD$42 Million Digital Health Innovation Hub in Singapore Eli Lilly and Company’s digital health arm, Lilly…
